NEWRON PHARMACEUT. EO-,20/ IT0004147952 /
07/06/2024 17:35:53 | Var. +0.020 | Volume | Denaro07/06/2024 | Lettera07/06/2024 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
10.320EUR | +0.19% | 3,060 Fatturato: 31,520.120 |
-Quantità in denaro: - | -Quantità in lettera: - | 182.21 mill.EUR | - | - |
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Dir...
GlobeNewswire
00:16
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages JBS S.A. Investors to Inquire About Securities Clas...
GlobeNewswire
08/06
Stockholder Alert: Robbins LLP Informs Investors of the Class Action Lawsuit Filed Against The Scott...
GlobeNewswire
08/06
Stockholder Alert: Robbins LLP Informs Investors of the Class Action Lawsuit Filed Against Gritstone...
GlobeNewswire
08/06
Stockholder Alert: Robbins LLP Informs Investors of the Class Action Lawsuit Filed Against Fat Brand...
GlobeNewswire
08/06
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel B...
GlobeNewswire
08/06
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...